REG - Futura Medical PLC - Notice of AGM <Origin Href="QuoteRef">FUM.L</Origin>

Futura MedicalAnnouncement

15/07/2015 14:39

RNS Number : 3043L
Futura Medical PLC
24 April 2015
For immediate release
24 April 2015
Futura Medical plc
("Futura" or "the Company")
Notice of AGM
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its notice of Annual General Meeting ("AGM"), including Explanatory Notes and Form of Proxy, has today been posted to shareholders. The AGM will be held at 4.00pm on 17 June 2015 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.
Futura's annual report and accounts for the year ended 31 December 2014 is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is available at the Company's website www.futuramedical.com.
Shareholders who would like to attend the AGM are invited to contact Buchanan on 020 7466 5000 or to email stephaniew@buchanan.uk.com.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0)1483 685 670
mail to:james.barder@futuramedical.com
www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Thomas Smale - Corporate Finance
Brough Ransom - Sales
Tel:+44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson
Tel: +44 (0)20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com 

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NOAUSVORVOASUAR